HFM
WST icon

Harvest Fund Management’s West Pharmaceutical WST Stock Holding History

Harvest Fund Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,705
Closed -$774K – 651
2025
Q4 		$774K Buy
2,705
+1,402
+108% +$383K 0.03% 210
2025
Q3 		$388K Hold
1,303
– – 0.02% 283
2025
Q2 		$386K Buy
1,303
+34
+3% +$7.27K 0.02% 269
2025
Q1 		$379K Buy
1,269
+357
+39% +$98.4K 0.02% 306
2024
Q4 		$299K Buy
+912
New +$287K 0.01% 411
2024
Q2 		– Sell
-781
Closed -$309K – 772
2024
Q1 		$309K Buy
781
+426
+120% +$158K 0.03% 260
2023
Q4 		$125K Sell
355
-325
-48% -$115K 0.02% 293
2023
Q3 		$255K Sell
680
-244
-26% -$94.4K 0.04% 187
2023
Q2 		$353K Buy
924
+498
+117% +$178K 0.07% 136
2023
Q1 		$148K Buy
426
+189
+80% +$55.2K 0.03% 255
2022
Q4 		$56K Sell
237
-534
-69% -$127K 0.01% 454
2022
Q3 		$190K Hold
771
– – 0.06% 196
2022
Q2 		$233K Sell
771
-312
-29% -$102K 0.06% 142
2022
Q1 		$444K Sell
1,083
-632
-37% -$247K 0.09% 103
2021
Q4 		$806K Buy
1,715
+499
+41% +$215K 0.14% 60
2021
Q3 		$516K Buy
1,216
+320
+36% +$135K 0.12% 61
2021
Q2 		$322K Hold
896
– – 0.03% 97
2021
Q1 		$252K Sell
896
-232
-21% -$66.4K 0.02% 119
2020
Q4 		$319K Sell
1,128
-676
-37% -$190K 0.03% 100
2020
Q3 		$518K Buy
1,804
+841
+87% +$223K 0.04% 84
2020
Q2 		$216K Sell
963
-131
-12% -$25.7K 0.02% 136
2020
Q1 		$167K Buy
1,094
+599
+121% +$92.2K 0.02% 140
2019
Q4 		$78K Hold
495
– – 0.01% 231
2019
Q3 		$70K Buy
+495
New +$68.2K 0.01% 235
2018
Q4 		– Sell
-407
Closed -$50K – 468
2018
Q3 		$50K Buy
+407
New +$45.6K 0.01% 363

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Harvest Fund Management's WST Position: Q1 2026 in Review

Harvest Fund Management sold out of West Pharmaceutical (WST) in Q1 2026, closing a stake of 2,705 shares — an estimated $774K sold.

Harvest Fund Management first reported a position in WST in Q3 2018 and held it in 25 quarters. The position peaked at $806K in Q4 2021. 755 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Harvest Fund Management reported no remaining West Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • Harvest Fund Management sold 2,705 West Pharmaceutical shares in Q1 2026, an estimated $774K.
  • Harvest Fund Management first reported a position in West Pharmaceutical in Q3 2018 and held it in 25 quarters.
  • Harvest Fund Management's West Pharmaceutical position peaked at $806K in Q4 2021.
  • 755 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Harvest Fund Management's 13F filing for Q1 2026, filed 14 May 2026.